PRPO
Precipio, Inc.
There isn't enough reported data to score PRPO yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
PRPO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Strong |
PRPO's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
PRPO PE Valuation
PRPO has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
PRPO Forward outlook
There aren't enough analyst estimates for PRPO to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
PRPO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.57 | +$0.24 |
| Q2 2026 | -$0.62 | +$0.56 |
| Q1 2026 | -$0.45 | +$1.61 |
| Q4 2025 | -$0.23 | +$2.70 |
| Q3 2025 | -$0.81 | +$1.24 |
| Q2 2025 | -$1.18 | +$1.49 |
| Q1 2025 | -$2.06 | +$1.58 |
| Q4 2024 | -$2.93 | +$1.85 |
PRPO is still losing money, but far less than before: $0.57 per share over the past year, against $52.60 at its worst in early 2020.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over PRPO on earnings quality, reporting a profit while its opponent remains loss making.
PRPO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.3M | +8.3% |
| Q2 2026 | $7M | +24% |
| Q1 2026 | $6.7M | +36% |
| Q4 2025 | $6.7M | +23% |
| Q3 2025 | $6.8M | +30% |
| Q2 2025 | $5.7M | +27% |
| Q1 2025 | $4.9M | +44% |
| Q4 2024 | $5.5M | +26% |
PRPO has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0% | +0.9 points |
| Q2 2026 | -8.5% | +6 points |
| Q1 2026 | -21% | -3.9 points |
| Q4 2025 | 8.1% | +14 points |
| Q3 2025 | -0.9% | +11 points |
| Q2 2025 | -15% | +13 points |
| Q1 2025 | -17% | +43 points |
| Q4 2024 | -6.2% | +14 points |
PRPO's operating margin was 0% last quarter, up 0.9 points from the same quarter a year ago, near the top of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over PRPO on profitability, with a higher operating margin.
PRPO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $554K | +$598K |
| Q2 2026 | $528K | +80% |
| Q1 2026 | $14K | +$196K |
| Q4 2025 | $291K | -44% |
| Q3 2025 | -$44K | +$24K |
| Q4 2024 | $521K | +702% |
| Q3 2024 | -$68K | +$851K |
| Q4 2023 | $65K | +$1.6M |
PRPO has the edge over UNH on cash flow, with more consistent year-over-year improvement.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
PRPO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.5K shares |
| 1 year | +9.4% | +153K shares |
| 3 years | +28% | +396K shares |
| 5 years | +58% | +655K shares |
| Available history | +529% | +1.5M shares |
PRPO has 2M diluted shares, up 9.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over PRPO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
PRPO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -59.9x | Net Cash |
PRPO has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
PRPO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 14.4 | Oversold |
PRPO's weekly RSI is 50 (neutral) and its Stochastic is 14 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
PRPO PE vs Healthcare Sector
PRPO has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
PRPO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.4 | 8.6% above |
| 20 week MA | $23.9 | 2.8% below |
| 50 week MA | $24.6 | 5.3% below |
| 100 week MA | $18.2 | 27% above |
| 200 week MA | $13.1 | 78% above |
PRPO's trend is mixed: it's above three of its five weekly moving averages, and 78% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over PRPO on trend strength, trading above more of its moving averages.
PRPO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.8 | $41.8 | +2.5% |
| 2021 | $41.8 | $35.6 | -15% |
| 2022 | $35.6 | $11.0 | -69% |
| 2023 | $11.0 | $6.50 | -41% |
| 2024 | $6.50 | $5.51 | -15% |
| 2025 | $5.51 | $23.8 | +331% |
| 2026 YTD | $23.8 | $23.3 | -2.1% |
PRPO's yearly returns have swung widely, from +331% in 2025 to −69% in 2022. It's down 2.1% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over PRPO on returns for 2026, with the stronger performance.